Nitric Oxide Induction by 5,6-Dimethylxanthenone-4-Acetic Acid
Author Information
Author(s): E Moilanen, LL Thomsen, DW Miles, L Happerfield, RG Knowles, S Moncada
Primary Institution: Wellcome Research Laboratories, Langley Court, Beckenham, Kent, UK
Hypothesis
The study aimed to investigate the profile of 5,6-MeXAA-induced nitric oxide synthesis in tumor and other tissues and the relationship between nitric oxide synthesis and the anti-tumor action of 5,6-MeXAA in immunocompetent mice bearing subcutaneous colon 38 tumors.
Conclusion
The experimental anti-tumor agent 5,6-MeXAA induced nitric oxide synthesis in tumor-associated macrophages and in immunologically active tissues, but nitric oxide is not a significant component in the mechanism of the anti-tumor action of 5,6-MeXAA in this model.
Supporting Evidence
- 5,6-MeXAA induced nitric oxide synthase in the tumor, spleen, thymus, and small intestine.
- The induction of nitric oxide synthase in the tumor was more persistent than in other tissues.
- Treatment with 5,6-MeXAA caused substantial increases in plasma nitrite and nitrate concentrations.
- Immunohistochemical staining suggested that nitric oxide synthase was located in macrophages and endothelial cells within and around the tumor.
- 5,6-MeXAA was shown to be a potent anti-tumor agent against solid murine tumors.
Takeaway
A drug called 5,6-MeXAA helps the body make a substance called nitric oxide, which is important for fighting tumors, but it doesn't work the way we thought it might.
Methodology
B6D2F1 mice were treated with 5,6-MeXAA, and nitric oxide synthase activity was measured in various tissues, along with plasma nitrite and nitrate concentrations.
Limitations
The study was conducted in a specific mouse model, which may not fully represent human responses.
Participant Demographics
B6D2F1 mice bearing subcutaneous colon 38 tumors.
Statistical Information
P-Value
p<0.001
Statistical Significance
p<0.001
Want to read the original?
Access the complete publication on the publisher's website